• BSE
  • NSE
    • {{d.cmpname}}
    • {{d.price}}
    • ({{d.PerChg}}%)
Equity | News | Hot Pursuit
Hot Pursuit
Glenmark Life reports Q3 PAT of Rs 105 cr
Back
(16:05, 27 Jan 2023)
The company's revenue from the Generic API segment increased 1.8% year on year to Rs 479.89 crore during the quarter driven by growth across all geographies. The regulated markets business continued the strong growth momentum. India, Europe and LATAM delivered strong performance while US witnessed healthy recovery.

CDMO revenues in Q3 FY23 decreased by 31.1% YoY to Rs 27.94 crore, demand is expected to be picked up from Q4 FY23.

EBITDA stood at Rs 152.06 crore for Q3 FY23 while EBITDA margin was 28.1%; remained steady on YoY basis with a slight sequential decline, mainly due lower gross margins.

Commenting on the company's performance, Dr. Yasir Rawjee, MD & CEO of Glenmark Life Sciences said, “I am pleased to report that the company has continued its upward trajectory to witness steady growth both on sequential as well as YoY basis on the back of a robust performance of our external business. India, Europe and LATAM were the main catalysts for growth whereas US witnessed healthy recovery. The GPL business saw strong recovery in the current quarter while the CDMO business was sluggish, and we expect it to pick up strongly from Q4 onwards.”

Dr. Rawjee further added, “During 9M FY23, we launched 5 new products, and we continue to cross sell our wide product basket to existing customers across different geographies. Overall, as the three levers of the business (external business, GPL and CDMO) are on track to perform well, I am confident of delivering steady growth with stable margins in the coming quarters.”

Tushar Mistry, CFO at Glenmark Life Sciences said, “The company continues to grow steadily with revenue from operations growing 3.5% on YoY basis and 6.2% sequentially. EBITDA for the quarter at 28.1% was steady on YoY basis. Our proactive cost control measures have helped us maintain our EBITDA margins for the nine-months at 30%.”“We are also witnessing increased capacity as Dahej block comes online. That said, we are strategically commissioning the Dahej block module-wise to keep expenses under control which will ensure steady margins in the coming quarters. Our prudent working capital management during the quarter has led to healthy cash flow generation from the operations. Reviving demand in the regulated markets and GPL business supported by excess capacity availability will propel growth in coming quarters,” he added.

Glenmark Life Sciences, a subsidiary of Glenmark Pharmaceuticals, is a developer and manufacturer of select high-value, non-commoditised active pharmaceutical ingredients (APIs) in chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes.

Shares of Glenmark Life Sciences closed 0.86% lower at Rs 386.60 on the BSE.

Powered by Capital Market - Live News

Top
Scores
Investor Charter
Investor Complaints
Advisory for Investors
KYC documents in vernacular languages
KYC documents in vernacular languages of commodities
.
Stock Broker Name Registration Number Registered Address Branch Address Contact Number Email id
DB (International) Stock Brokers Limited INZ000179035 (BROKING)

IN-DP-CDSL-266-2004 (DEPOSITORY) 		Unit No. 210/211/211A at 2nd floor, Dalal Street Commercial Cooperative Society Ltd, Block No.53, Zone 5, Gift City, Gandhinagar, Gujarat-382355 Head Office – 114, New Delhi House, 27 Barakhamba Road, Delhi 110001 011-43606162 compliance@dbonline.in
51, Mini Market T/F Mandir Wali Gali, Yusuf Sarai, New Delhi 110016 011-35936102 greenpark@dbonline.in
C-12, DB Plaza, RDC Raj Nagar, Ghaziabad 2012002 0120-4150393 ghaziabad@dbonle.in
827, Tower B3, Spaze I Tech Park, Sector 49, Sohna Road, Gurgaon, Haryana – 122001 0124-4383584 sanjay05@dbonline.in
Plot No 4, Wasme House, Film City Sector 16A, Noida – 201301 0120-4823200 compliance@dbonline.in
Out Side Jassusar Gate, Bikaner, Rajasthan – 334001 9001643408 bikaner@dbonline.in
Office No 101, City Center, Opp. High Court, M G Road, Indore 452001 9424083019 brajeshsadani@dbonline.in
203, Marshal House 25, Strand Road, Kolkata 700001 033-40055270 b032@dbonline.in
Shop No.-7, 2nd Floor, Amar Complex, Opp. Hanumaan Mandir, The Mall, Solan- 173212 6230604596 parwanoo@dbonline.in
Daga Commodities Private Limited INZ000028833 114, New Delhi House, 27 Barakhamba Road Delhi New Delhi DL 110001- 0120-4823200 compliance@dbonline.in
DAGA BUSINESS (INTERNATIONAL) STOCK BROKERS IFSC PRIVATE LIMITED - Unit No. 228, Signature Building, Second Floor, Block 13B, Zone-1, GIFT SEZ, Gandhinagar,Gujarat 382355 - 0120-4823200 compliance@dbonline.in
Investor Grievances Email ID: investors@dbonline.in
Copyright © 2016 All rights Reserved DB (International) Stock Brokers Ltd.     Designed, Developed and content powered by C-MOTS Infotech( ISO 9001:2015 certified )
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."         "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors."          "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Attention Investors ::
subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries | Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. | Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month........... Issued in the interest of Investors"